UNSPSC 51342309: Aciclovir or acyclovir

This classification denotes a purine antagonist and antiviral agent with the molecular formula C8H11N5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X4HES1O11F, chemically known as 6h-purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)- but generally known as aciclovir, which bears US NIH Compound Identifier 2022. Aciclovir, also known as acyclovir, most often comes in forms natrium and sodium.

UNSPSC 51342309 Aciclovir or acyclovir is a Commodity code for a specific antiviral pharmaceutical product, yet the most recent state and local opportunities tagged under this code show little activity directly aligned with acyclovir procurement. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride — neither of which is acyclovir — under an Invitation for Bid process that closed on September 11, 2026. A second opportunity from Seminole County, Florida, solicited Naloxone and Safe Drug Deactivation Systems through an IFB, also unrelated to acyclovir. The mismatch between the code's nominal scope and the recent opportunities suggests that this Commodity code sees limited state and local procurement activity at present, or that tagging inconsistencies have placed non-acyclovir pharmaceuticals under the code in the sourced records.

Activity appears concentrated in Florida and Illinois based on the available records, with no additional states represented in the recent opportunities block. The Illinois contract awarded to Chartwell Rx LLC carried a total value of $2,999,999.11 over 12 months plus two renewal years; the Seminole County procurement called for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries, though the source does not support a dollar value. State and local demand for acyclovir itself — whether through piggyback arrangements, competitive bidding, or direct purchase — is not evident in the recent solicitations indexed under this code. Business development professionals pursuing this code should verify current tagging accuracy with state health departments and pharmaceutical cooperative purchasing groups before committing resources.